CLINICAL ROLE -
Study Links Gut Bacteria with Chemoresistance to Colorectal Cancer
Bacterium may hold the key to preventing resistance to chemotherapy.
Read More
Ibrutinib Granted Expanded Indication for Chronic Graft Versus Host Disease
Imbruvica is the first FDA-approved therapy to treat cGVHD.
HIV-Preventive Vaginal Ring Found Safe, Acceptable Among Adolescents
Scientists say ring containing pre-exposure prophylaxis and Truvada is safe in US teens, now need data in African adolescent girls.
FDA Approves Revisions to Epclusa Label to Include Co-Infection Clinical Trial Data
The label has been updated to include data from adults co-infected with hepatitis C virus and HIV-1.
Trending News Today: Express Scripts Favors Mylan's EpiPen, Excludes Alternatives
Top news of the day from across the health care landscape.
First Oral Therapy Approved to Treat Relapsed or Refractory AML and IDH2 Mutation
Enasidenib, an oral inhibitor for relapsed or refractory acute myeloid leukemia, shows promise in achieving a complete response with hematologic improvement.
Excess Cardiovascular Risk Linked to Rheumatoid Arthritis Less Prevalent Since 2000
New treatment strategies for rheumatoid arthritis led to a reduction in congestive heart failure and cardiovascular mortality after the year 2000.
Surgeons Combat PET Scan Limitations by Illuminating Lung Tumors
Combining old and new technology may provide superior oncologic outcomes for patients with resectable lung cancer.
Interchangeability Clinical Study Between Adalimumab, Biosimilar Candidate Enrolls First Patient
Study will compare the pharmacokinetics and clinical outcomes between Humira biosimilar and its reference product in the treatment of moderate-to-severe chronic plaque psoriasis.
Trending News Today: Drug-Resistant Gonorrhea on the Rise
Improved Testing Reduces HIV Infections in Some African Regions
Increased efforts in prevention and treatment for HIV show promise in high-burden regions.
Former Lilly USA President, Health Care Expert to Give Keynote at NASP Conference
The upcoming National Association of Specialty Pharmacy conference will focus on the evolution of the industry.
Trending News Today: FDA Seeks Nicotine Reduction in Cigarettes
Transgender Women Voice Concerns About Potential Harmful HIV Drug Interaction with Hormones
More than half of survey respondents with HIV reported concerns about possible drug-drug interactions.
Concurrent Chemotherapy, High-Dose Proton Beam Radiotherapy Show Promise in Advanced Lung Cancer
Technique offers improved survival in patients with advanced, inoperable stage 3 non-small cell lung cancer.
Several Barriers Promote Non-Adherence to Statins Among Stroke Survivors
One-third of strokes worldwide occur in stroke survivors.
Underlying Mechanisms of HIV-Associated Neurocognitive Disorders
HIV patients lack crucial peroxisomal proteins in the brain.
Trending News Today: 'Skinny' Repeal Bill Fails in Senate
World Hepatitis Day: New WHO Data Reveal Why We Should Care, How Far We Have Come
Approximately 325 million individuals are living with hepatitis worldwide.
The Voices of Hepatitis C: Patients Discuss Their Fight Against HCV for World Hepatitis Day
Those who battled hepatitis C recount their journey to spread awareness on World Hepatitis Day.
In-Depth Look at the World of Specialty Pharmacy: NASP Releases Upcoming Conference Agenda
The annual meeting of the National Association of Specialty Pharmacy will take place this September in Washington, DC.
Dolutegravir-Based Regimen Demonstrates Superior Efficacy to Current WHO-recommended HIV Regimen
Response rate higher among patients with HIV treated with dolutegravir compared with lopinavir/ritonavir.
Trending News Today: More Than 250 Contaminants Found in US Water Supplies Pose Health Risks
HIV Suppression Maintained After Switch to Dolutegravir Regimen
Dolutegravir-based treatment non-inferior to boosted protease inhibitor regimen in virally suppressed HIV-positive patients.
Neoadjuvant Therapy Reduces Risk of Secondary Primary Cancer in Early-Stage Breast Cancer
Investigators compare long-term overall and disease-free survival rates in neoadjuvant versus adjuvant radiotherapy.
Trending News Today: Latest Version of ACA Replacement Bill Rejected in Senate
Investigational Doravirine Non-Inferior to Efavirenz for HIV-1 Infection
Fixed-dose combination tablet containing doravirine achieved viral suppression in HIV-1 infected treatment-naïve adults.
Scientists Examine Cow Immune System as Another Avenue for HIV Vaccine
Immunization of cows induces rapid elicitation of broadly neutralizing antibodies to HIV.
Cell Partnership Exploited by Cancer to Turn Off Immune Response
Novel approach may improve efficacy of pancreatic cancer treatments.
Comparison of Algorithms May Reveal New Cancer Treatment Targets
Tools that analyze the cancer genome provide new insight into the mechanisms that drive cancer development.